Snake bite in South Asia: a review by Alirol, Emilie et al.
Review
Snake Bite in South Asia: A Review
Emilie Alirol
1*, Sanjib Kumar Sharma
2, Himmatrao Saluba Bawaskar
3, Ulrich Kuch
4, Franc ¸ois Chappuis
1
1Division of International and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland, 2B. P. Koirala Institute of Health Sciences, Dharan, Nepal,
3Bawaskar Hospital and Research Centre, Raigad, India, 4Biodiversity and Climate Research Centre, Frankfurt am Main, Germany
Abstract: Snake bite is one of the most neglected public
health issues in poor rural communities living in the
tropics. Because of serious misreporting, the true world-
wide burden of snake bite is not known. South Asia is the
world’s most heavily affected region, due to its high
population density, widespread agricultural activities,
numerous venomous snake species and lack of functional
snake bite control programs. Despite increasing knowl-
edge of snake venoms’ composition and mode of action,
good understanding of clinical features of envenoming
and sufficient production of antivenom by Indian
manufacturers, snake bite management remains unsatis-
factory in this region. Field diagnostic tests for snake
species identification do not exist and treatment mainly
relies on the administration of antivenoms that do not
cover all of the important venomous snakes of the region.
Care-givers need better training and supervision, and
national guidelines should be fed by evidence-based data
generated by well-designed research studies. Poorly
informed rural populations often apply inappropriate
first-aid measures and vital time is lost before the victim
is transported to a treatment centre, where cost of
treatment can constitute an additional hurdle. The
deficiency of snake bite management in South Asia is
multi-causal and requires joint collaborative efforts from
researchers, antivenom manufacturers, policy makers,
public health authorities and international funders.
Introduction
Since ancient times, snakes have been worshipped, feared, or
loathed in South Asia. Cobras appear in many tales and myths and
are regarded as sacred by both Hindus and Buddhists.
Unfortunately, snakes remain a painful reality in the daily life of
millions of villagers in this region. Indeed, although antivenom is
produced in sufficient quantities by several public and private
manufacturers, most snake bite victims don’t have access to quality
care, and in many countries, both morbidity and mortality due to
snake bites are high. The neglected status of snake bite
envenoming has recently been challenged [1] but as outlined
below, apart from the production of antivenom, snake bite
envenoming in South Asia shares all the characteristics of a
neglected tropical disease. This review aims at summarizing and
discussing the epidemiology, clinical features, diagnosis, and
treatment of snake bite envenoming in South Asia (Bangladesh,
Bhutan, India, Nepal, Pakistan, and Sri Lanka).
Methodology
Articles were identified by searching Medline through PubMed
using various combinations of terms including ‘‘snake,’’ ‘‘snake
bite,’’ ‘‘envenoming,’’ and ‘‘venom.’’ Research papers and case
reports from Bangladesh, Bhutan, India, Nepal, Pakistan, and Sri
Lanka were retrieved, as were significant papers from other Asian
countries. Additional articles were obtained by citation tracking of
review and original articles. The review also drew on conference
proceedings and original research conducted by the authors.
Epidemiology
An accurate measure of the global burden of snakebite
envenoming remains elusive despite several attempts to estimate
it and, apart from a few countries, reliable figures on incidence,
morbidity, and mortality are scarce [2–4]. South Asia is by far the
most affected region [2,4]. India has the highest number of deaths
due to snake bites in the world with 35,000–50,000 people dying
per year according to World Health Organization (WHO) direst
estimates [2,4]. In Pakistan, 40,000 bites are reported annually,
which result in up to 8,200 fatalities [4,5]. In Nepal, more than
20,000 cases of envenoming occur each year, with 1,000 recorded
deaths [6]. In Sri Lanka, around 33,000 envenomed snake bite
victims are reported annually from government hospitals [4,7]. A
postal survey conducted in 21 of the 65 administrative districts of
Bangladesh estimated an annual incidence of 4.3 per 100,000
population and a case fatality of 20% [8]. However, existing
epidemiological data remain fragmented and the true impact of
snake bites is very likely to be underestimated. Surveys in rural Sri
Lanka showed that hospital data record less then half of the deaths
due to snakebite [9–11]. In Nepal, a review of district hospital
records showed that national figures underestimated the incidence
of snake bite by one order of magnitude [12]. The highest figures
reported in Asia so far come from a community-based survey
conducted in southeast Nepal in 2002, which revealed annual
incidence and mortality rates of 1,162/100,000 and 162/100,000,
respectively [13]. Figures of a similar magnitude were recently also
obtained in a nation-wide community-based survey in Bangladesh
(M. R. Rahman, personal communication).
Snake bite is an important occupational injury affecting farmers,
plantation workers, herders, and fishermen. Open-style habitation
and the practice of sleeping on the floor also expose people to bites
from nocturnal snakes. As summarized in Table 1, several
epidemiological studies have outlined characteristics of snake bite
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generally occur on lower limbs. The incidence of snake bites is
higher during the rainy season and during periods of intense
agricultural activity [14,15]. Snake bite incidence and mortality
also increase sharply during extreme weather events such as floods.
During the 2007 monsoon flood disaster in Bangladesh, snake bite
was the second most common cause of death, after drowning,
eclipsing mortality from diarrheal and respiratory diseases and
illustrating how important snake bite can be in this region
compared to other health problems [16].
Venomous Snakes in South Asia
The number of different snake species found south of the
Himalayas is estimated to be around 300, including about 67
front-fanged venomous species of the families Elapidae and
Viperidae [17–21].
Viperid snakes are represented by 26 species belonging to the
true vipers (subfamily Viperinae) and pit vipers (Crotalinae).
Among the true vipers, Russell’s viper (Daboia russelii) is associated
with the highest morbidity and mortality. In Anuradhapura
District, Sri Lanka, up to 73% of all admitted snake bites are
attributed to this species [22] whose distribution extends north to
the Indus valley of Pakistan and Kashmir, to the foothills of the
Himalayas in Nepal and Bhutan and to Bangladesh in the east.
Saw-scaled vipers (Echis carinatus and E. sochureki) are other very
important viperine species that inhabit open and dry environ-
ments. E. sochureki causes numerous bites in northern India and has
long been regarded as one of Pakistan’s deadliest snakes [17,23];
E. carinatus is regionally highly abundant and causes many bites in
parts of western and southern India [18] and in arid coastal areas
of northern Sri Lanka [24]. Three other species of true vipers that
occur in the west of South Asia are the Levantine viper (Macrovipera
lebetina) and two species of desert vipers (Eristicophis macmahoni and
Pseudocerastes persicus). Although their bites have been considered to
be comparatively rare, they are capable of causing severe
envenoming [25,26].
Pit vipers belonging to various genera [27,28] have traditionally
been regarded as being of lesser concern in South Asia. However,
these snakes occur in most habitat types from mangroves to the
high mountains, and some species are common in gardens and
agricultural landscapes. Envenoming by green pit vipers is very
common in wide regions of Bangladesh and Nepal [12,29], and
bites by the mountain pit viper (Ovophis monticola) occur in Nepal
where it is the most frequently encountered venomous snake at
altitudes of 900–2,700 m [21,30]. Although causing few fatalities,
bites by these species produce marked local effects that can result
in chronic conditions and permanent sequelae [31,32]. In
southern India, recent studies have reported massive morbidity
among plantation workers due to bites by a much smaller species,
the Malabar pit viper (Trimeresurus malabaricus) [33]. Hump-nosed
pit vipers (Hypnale hypnale and H. nepa) are also emerging as
medically important species in the region, and can cause renal
failure and haemostatic dysfunctions [34,35]. Several fatalities due
to H. hypnale envenoming, for which there is no specific antivenom,
were reported in India and Sri Lanka [34,36,37].
The family Elapidae is represented by at least 17 terrestrial
species (including cobras, king cobras, kraits, and coral snakes) and
numerous species of sea snakes in South Asia. Bites by cobras (Naja
species), which are best known for raising their head and anterior
body and spreading their neck as a hood in defence, typically
occur outdoors in the late afternoon [17,18]. The spectacled cobra
(Naja naja), one of India’s commonest snakes, causes numerous
cases of envenoming every year [38]. In the northern and eastern
parts of the Indian subcontinent, the monocellate cobra (N.
kaouthia) also belongs to the medically important snakes. A third
cobra species, N. oxiana, occurs in the northwest [18,20,21]. Kraits
(Bungarus species) are slender, nocturnal snakes that often enter
human dwellings at night in search of prey. Consequently, many
victims of krait bites are bitten while asleep. Case fatality rates of
krait envenoming reach up to 77%–100% without treatment
[17,39]. Traditionally, most krait bites in South Asia have been
attributed to the common krait (Bungarus caeruleus), however, in
South Asia alone there are eight species of Bungarus, several of
which are morphologically similar to B. caeruleus. Several studies
have demonstrated that a number of these are medically important
in the region [40–43]. Coral snakes are smaller elapid snake
species that are brightly coloured. They are rarely encountered by
Table 1. Characteristics of snake bite victims in South Asia.
Characteristic Details References
Age The mean age of snake bite victims is around 30 years. Three-quarters of the victims
are in the 10- to 40-year age group, broadly in agreement with demography.
[7,9,12,14,15,22,37,40,49,55,56,76,88,89,93,94,97,104,111–119]
Gender There is a clear preponderance of males among snake bite victims. A 2:1 male
to female ratio is frequently observed.
[7,9,12,14,15,22,37,40,49,55,56,76,88,89,93,94,97,104,111–119]
Occupation Farmers account for more than half of the victims. Students and housewives
are also frequently bitten.
[9,13,15,22,40,56,93,114,117,120]
Time of bite The time of bite depends on the relative abundance of diurnal and nocturnal
snakes. Krait bites generally occur at night, whereas viper and cobra bites
mostly occur during daytime.
[7,9,12,14,15,22,37,49,56,88,89,94,97,104,114–117]
Site of bite 60%–80% of bites occur on the foot, ankle, or leg. Bites on the head and trunk
are mostly due to nocturnal species biting sleeping people.
[7,9,12,14,15,22,40,49,56,76,77,88,93,97,104,114–118,121,122]
Delay between
bite and
treatment
The bite-to-treatment delay varies greatly, ranging from 30 minutes to 15 days.
Most studies show that at least 60% of victims reach a health centre within six
hours but very few in less than one hour.
[7,12,14,15,22,40,49,55,56,74,88,93,94,104,113–119,121]
First aid
methods
In eight out of 15 studies, more than 50% of snake bite victims used inappropriate
and harmful first aid methods. Tourniquets are used by up to 98% of patients.
[7,9,13,22,40,49,74,76,88,93,104,113,115–117,119]}
Mortality Mortality rates are highly variable, ranging from 0.5% to 58%. Most fatalities
occur before reaching treatment centres.
[7,9,12–15,22,37,49,55,56,76,88,89,93,94,97,104,111,113–121]
doi:10.1371/journal.pntd.0000603.t001
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been reported [44]. Sea snakes are large, paddle-tailed and
primarily marine snakes that feed on fish and fish eggs. They are
often caught in the nets of fishermen who are at risk of bites while
handling them. Most fatalities following sea snake bites are
attributed to Enhydrina schistosa [45] but the species identity of sea
snakes involved in bites in South Asia has only very rarely been
established [46,47].
An often overlooked problem is that of nonvenomous or mildly
venomous species. They represent the vast majority of living
snakes, and may be mistaken for venomous snakes and/or
involved in snake bite in South Asia. Rat snakes (Ptyas species,
Coelognathus species) are large, rapidly moving snakes that are often
confused with cobras. Most notoriously, several genera of small
nonvenomous snakes share the same colour pattern as kraits
[19,48]. Wolf snakes (Lycodon species) are of particular concern in
this regard because some of them (e.g., Lycodon aulicus) are very
common inside and around houses and bite aggressively if
disturbed [40].
This species diversity has a significant public health impact: in
addition to increasing the risk of bites in all kinds of environments,
it complicates clinical management with respect to both diagnosis
and treatment, as well as antivenom design and manufacture and
control strategies.
Clinical Features of Snake Bite Envenoming
A widespread belief is that snake bites inevitably result in
envenoming. However, bites by nonvenomous snakes are common
and bites by venomous species are not always accompanied by the
injection of venom (dry bites). A large survey conducted in ten
hospitals of southern Nepal revealed that envenoming occurred in
only 10% of the victims [12]. In Kerala, India, only 219 out of 635
patients (34%) with proven snake bite developed signs of systemic
envenoming [49]. Likewise, in Bangladesh the proportion of
nonenvenomed bites reported in hospital-based studies varied
between 60% and 80% [29,50]. Moreover, as symptoms
associated with panic or stress sometimes mimic early envenoming
symptoms, clinicians may have difficulties in determining whether
envenoming occurred or not.
When envenoming does occur, it can be rapidly life-threatening.
Snake venom is a complex mixture of toxins and enzymes, each of
which may be responsible for one or more distinct toxic actions. In
bites by South Asian viperid snakes, envenoming results in local
pain and tissue damage, characterised by swelling, blistering,
bleeding, and necrosis at the bite site, sometimes extending to the
whole limb [17]. Viperid venoms can also induce coagulopathy and
platelet dysfunction, leading to spontaneous systemic haemorrhages
and persistent bleeding from fang marks, wounds, or gums
(Figure 1). Intracranial bleeding, including anterior pituitary
haemorrhage, and multi-organ failure are common causes of death
[51]. A prospective study conducted in Anuradhapura District, Sri
Lanka, showed that 92% of patients with Russell’s viper
envenoming presentedwithlocalswellingand77%hadhaemostatic
disturbances [7]. In addition, Russell’s viper can cause acute renal
failure and neurotoxicity, as has been shown in several studies
conducted in south India and Sri Lanka [7,22,49,52].
Among the Elapidae, bites by N. naja and N. kaouthia can cause
significant local swelling and sometimes extensive tissue necrosis of
the bitten limb [31,38,53], whereas bites by kraits or sea snakes do
not usually cause signs of local envenoming and can be virtually
painless. Cobra venom contains mainly postsynaptic neurotoxins,
which bind and block acetylcholine receptors of the neuromuscu-
lar junction, while krait venom in addition contains presynaptic
toxins that damage nerve endings [54]. Progressive descending
paralysis is the hallmark of systemic envenoming by elapid snakes
in South Asia (Figure 2). Extraocular muscles are particularly
sensitive to neuromuscular blockade, leading to a droop of upper
eyelids (bilateral ptosis), a frequently observed early sign of
paralysis [55]. Patients are often unable to protrude their tongue
beyond the incisors and may present with difficulty speaking or
swallowing. Limb weakness, loss of deep tendon reflexes, and fixed
dilated pupils may follow. Once paralysis reaches the diaphragm
and the intercostal muscles, victims usually die of respiratory
failure if they are not adequately ventilated. Hospital-based studies
in Sri Lanka showed that 48%–64% of B. caeruleus victims
developed respiratory paralysis and required mechanical ventila-
tion [15,56]. Although many clinical signs of neurotoxic
envenoming by cobras and kraits are similar, with both genera
able to cause respiratory failure within 30 minutes of the bite
[57,58], krait bite envenoming is often associated with a delayed
onset and prolonged total period of paralysis. This is due to the
function and effects of the most lethal components of krait venoms,
beta-bungarotoxins, which destroy nerve terminals [59]. While
coagulopathy and bleeding are common features of envenoming
by certain elapid snakes in Australia and New Guinea [60], clinical
bleeding and clotting problems have not been reported after bites
by South Asian elapids. Likewise, systemic myotoxicity following
elapid snake bites was previously known only from sea snakes and
some of their terrestrial relatives in Australia and New Guinea
[60]. However, venom-induced generalized rhabdomyolysis and
renal failure has recently also been observed in envenoming by the
greater black krait (B. niger) in Bangladesh, further complicating
clinical management (Faiz et al., unpublished data).
Diagnosis
The identification of snake species is crucial for optimal clinical
management, because it allows clinicians to choose the appropri-
ate treatment, anticipate complications, and therefore to improve
prognosis. Moreover, as specific antivenoms are not available for
South Asian pit vipers and most krait species, identifying these
species would help to avoid wasting this expensive treatment and
exposing patients to antivenom-induced adverse reactions. As
mentioned above, bites by nonvenomous species are common and
may throw clinicians into confusion.
Figure 1. Gum bleeding after bite by Russell’s viper. In Asia,
coagulation defects and spontaneous bleeding are characteristic of
bites by viperid snakes and are caused by procoagulant and
haemorrhagic toxins in the snake venom. Image credit: D. A. Warrell.
doi:10.1371/journal.pntd.0000603.g001
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it is, its description by the victim is often misleading [40]. Even
when the dead snake is brought to the health centre, misidenti-
fication is common. For example, hump-nosed pit vipers (H.
hypnale) are frequently misidentified as saw-scale vipers (E. carinatus)
in Kerala, India [34]. Consequently, many H. hypnale bite victims
end up receiving ineffective antivenom. Throughout South Asia,
krait bites are routinely attributed to B. caeruleus based on clinical
syndromes and the great superficial similarity of B. caeruleus, B.
sindanus, and B. walli. However, envenoming by krait species other
than B. caeruleus that does not respond to available antivenoms may
be common, as observed in Bangladesh (Faiz et al., unpublished
data; Kuch et al., unpublished data).
Most physicians in South Asia have to rely on the circumstances
of the bite and the clinical features of envenoming to infer the
biting species. Coagulopathy, when present, is diagnostic of viper
and pit viper bites in South Asia and can be observed using the 20-
minute whole blood clotting test [61]. In Sri Lanka, B. caeruleus
envenoming has a characteristic epidemiologic and clinical pattern
[15]. Syndromic approaches have been proposed to assist
physicians in identifying the biting species [61] and attempts have
been made to develop clinical scores based on envenoming
features [62]. However, careful studies of envenoming profiles are
lacking for most species in this region. Thus, more clinical research
using reliably identified snakes is needed to further explore
differences in envenoming syndromes between additional species,
and to evaluate their applied utility.
Immunoassays for detecting venom antigens in body fluids have
been described for a number of species [63–65], and attempts have
been made to develop ELISA tests for South Asia [66–68].
Unfortunately, a narrow focus on an insufficient number of species
and cross-reactivity between venoms has so far hindered the
development of a reliable diagnostic test [64,69]. To limit the
problem of cross-reactivity, the use of purified species-specific
toxins for immunization or affinity-purified venom-specific
polyclonal antibodies may be worth considering [70]. However,
even then the paucity of reliable data on the diversity and
distribution of venomous snakes in South Asia, the unavailability
of venom for almost all of the species, and the very limited insight
into venom variability even within the commonest species—all
caused or promoted by restrictive wildlife legislation—remain
major obstacles for the design and production of immunodiagnos-
tics. Under these aspects, the use of forensic molecular techniques
as an explorative and complementary tool for snake species
diagnosis is promising. Forensic routine has shown that it is
feasible to identify an aggressor (e.g., human or dog) based on
trace DNA from bite marks [71], and this is also possible in the
case of snakes [72]. PCR amplification and sequencing of snake
DNA obtained from bite-site swabs has recently been used to
identify biting snakes in an animal model and in clinical cases from
Bangladesh and Nepal (Kuch et al., unpublished data). The utility
of this method as a clinical diagnostic tool, however, awaits further
study.
Management of Snake Bite Victims and
Recommended Treatment
Health workers in rural districts are usually poorly trained to
manage snake bite envenoming, which is a complex emergency. A
recent survey conducted in India and Pakistan showed that many
doctors were unable to recognize systemic signs of envenoming
[73]. Another study in northwest India revealed that most snake
bite victims presenting at primary health centres received
inadequate doses of antivenom and that out of 42 patients who
required assisted ventilation, only one was intubated [74].
Improving the knowledge of care-givers at all levels of the health
system is a challenge of paramount importance and great urgency
in South Asia. Papua New Guinea, where snake bite management
training programmes have been implemented in both rural and
urban hospitals, could serve as an inspiring model in this regard.
First aid
Most experts agree that snake bite victims should be transported
as quickly as possible to a medical centre where they can be
clinically evaluated by qualified medical staff, and where
antivenoms are available. In fact, time of transport was shown to
be a crucial determinant of snake bite mortality in eastern Nepal
[13], and studies in southern India confirmed that delayed
antivenom administration was associated with an increased risk
of complications [49,75]. The bite victim should be reassured, the
bitten limb immobilized with a makeshift splint or sling, and the
patient transported. Walking is contraindicated, because muscular
contractions promote venom absorption.
These simple recommendations are unfortunately rarely
followed and vital time is often lost. The majority of victims first
report to traditional healers [10,40,55,76]. Popular traditional
Figure 2. ‘‘Broken neck’’ sign observed in a 14-year-old girl
bitten by a Russell’s viper in India. Envenoming by cobras, kraits
and—in some areas—by Russell’s viper frequently leads to progressive
descending paralysis. Looking for the broken neck sign, which is caused
by paralysis of the neck flexor muscles, should be part of the routine
clinical assessment of patients. In this case, neuroparalysis persisted for
five days despite antivenom treatment, but without progression toward
respiratory failure. Image credit: H. S. Bawaskar.
doi:10.1371/journal.pntd.0000603.g002
www.plosntds.org 4 January 2010 | Volume 4 | Issue 1 | e603treatments include chanting, incisions, attempts to suck venom
from the bite site, and the application of herbal medicine or snake
stones. Two studies in Nepal and Bangladesh showed that 90%
and 98% of snake bite victims, respectively, used tourniquets
(Figure 3) [40,77]. In Bangladesh, incisions at and around the bite
site were made in 28% of envenomed victims and in 13%–14% of
those without signs of envenoming [40]. In northwest India,
incision and drainage were practiced by 20% of patients [74].
These traditional measures are strongly contraindicated as they
are ineffective and in most cases deleterious. For example,
tourniquets cannot be safely left on for long without risking severe
local damage including ischemia, necrosis, and gangrene [78,79].
In 1979, Sutherland et al. recommended the pressure-
immobilization method as an effective alternative first aid
method [80]. According to the authors, the bitten limb should
be bound firmly with a crepe bandage, starting distally around
the toes or fingers and moving proximally. Although this
technique has been extensively promoted in Australia, its efficacy
remains controversial [81]. For example, a recent study in
Australia showed that crepe bandages rarely generated optimal
pressures compared with elasticized bandages [82]. In a study in
India, pressure-immobilization was found to be difficult to apply
correctly despite intense previous training of care providers [83].
In the Australian study, training did improve participants’ ability
to apply elasticized bandages [82], and in a study in Papua New
Guinea, participants living in an area where snake bites are
common were very successful in gaining and retaining the ability
of correctly applying pressure-immobilization (D. Williams,
personal communication). This method is, however, contraindi-
cated for viper and cobra bites as it may increase local tissue
damage [81,84] and may contribute to delaying transport of the
victim to a treatment centre.
Antivenoms
Immunotherapy is the only specific treatment for snake bite
envenoming. Antivenoms are produced by fractionation of plasma
obtained from immunized animals, usually horses [85]. They can
be either monovalent or polyvalent, depending on the number of
species (single or multiple, respectively) whose venoms are used for
immunization. Although monovalent antivenom has often been
considered more efficacious, the production of polyvalent
antivenom is preferred in many countries as snake species
identification is generally not possible for the attending physician.
Antivenoms have been available in South Asia for the past 60
years, and all existing products are manufactured by Indian
companies. Traditionally, the production has focused on four
species believed to be responsible for most deaths: N. naja, B.
caeruleus, D. russelii, and E. carinatus. However, a number of other
species that contribute to morbidity and mortality in the region
have not been considered, and envenoming by these species
usually does not respond adequately to existing antivenoms
[34,36].
The success of antivenom therapy depends on the ability of
immunoglobulins to bind, extract, and eliminate toxins present in
the body. While their efficacy in restoring haemostasis and
cardiovascular functions is well established, the ability of
antivenoms to prevent tissue damage and to reverse neurotoxicity
is more controversial [56,86,87]. For instance, administration of
antivenom to krait bite victims with established respiratory
paralysis does not reverse paralysis [55,86,87]. This lack of clinical
effectiveness often contributes to the administration of excessive
amounts of antivenom [88,89]. Moreover, treatment outcome can
vary greatly with the geographical area as the venom composition
and antigenic properties of toxins can be highly variable across the
range of a given snake species [90,91]. Indian antivenoms are
produced using venoms from snakes captured in a tiny geographic
area of the State of Tamil Nadu, and may therefore be less
effective in other regions [92]. For example, the efficacy of Indian
polyvalent antivenoms for the treatment of envenoming by
Russell’s viper in Sri Lanka is controversial [22,93].
As a matter of fact, most of the antivenoms that are routinely
used in South Asia have never been subjected to independent
preclinical testing and formal evaluation in clinical trials. Their
efficacy and safety profiles have not been properly established, and
there is currently no evidence-based protocol for their adminis-
tration and dosage. Up to 80% of patients treated with Indian
antivenoms present one or more adverse effect(s) such as
anaphylactoid or pyrogenic reactions, or late serum sickness
[37,93,94]. While to our knowledge no fatal cases have been
reported in South Asia, severe drug reactions occur and are likely
to be under-reported. Adverse reactions can be efficiently
managed by cheap, widely available drugs (e.g. antihistaminics,
corticoids, adrenalin), but their prophylactic use yielded contra-
dictory results [94–96]. The risk of severe adverse events exists but
must be balanced against the life-saving potential of this treatment.
Antivenoms may be supplied free of cost by some ministries of
health but their supply remains insufficient and irregular in several
countries [12], leading to the purchase of drugs by the patients’
Figure 3. Tourniquet on a 43-year-old woman presenting at a
rural health post in Nepal. First-aid methods applied throughout
South Asia are largely inadequate. Tourniquets in particular can have
deleterious effects. This patient consulted after being bitten by a
nonvenomous rat snake (Ptyas mucosa) that she had killed and brought
for identification. After reassurance, local treatment, and observation,
she was uneventfully discharged from the health post. Image credit: E.
Alirol.
doi:10.1371/journal.pntd.0000603.g003
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US$8–10, which is equivalent to several days of salary for poor
farmers. Thus, many cannot afford to purchase the average 10–15
vials needed to reverse envenoming [97].
Ancillary treatment
The management of envenomed snake bites is not limited to the
administration of antivenoms. In the case of neurotoxic enven-
oming, artificial ventilation and careful airway management are
crucial to avoid asphyxiation in patients with respiratory paralysis.
Cases of complete recovery from severe neuromuscular paralysis
without antivenom have been reported after prolonged artificial
ventilation [98].
Anticholinesterase drugs such as edrophonium can partly
overcome blockade by postsynaptic neurotoxins and have
shown good efficacy in cobra bite envenoming [61,99]. A few
cases of successful anticholinesterase use have also been
reported in krait bite envenoming in India [100], but there is
currently no treatment to stop the destruction of nerve endings
by presynaptic krait toxins once this degeneration process has
started.
Bacterial infections can develop at the bite site, especially if the
wound has been incised or tampered with nonsterile instruments,
and may require antibiotic treatment. However, there are
currently no data supporting their systematic use [101]. A booster
dose of tetanus toxoid should be administered but only in the
absence of coagulopathy [17]. Necrosis on the bitten limb may
require surgery and skin grafts, particularly in the case of cobra
bites. If necrotic tissues are not removed, secondary bacterial
infections can occur [53]. Tensed swelling, pale and cold skin with
severe pain may suggest increased intracompartmental pressure in
the affected limb. However, fasciotomy is rarely justified. In
particular, it can be disastrous when performed before coagulation
has been restored. A clear proof of significant compartment
syndrome by measurement of substantially elevated intracompart-
mental pressures is a prerequisite [61].
Box 2. Five Key Papers in the Field
1. Kasturiratne A, Wickremasinghe AR, de Silva N, Guna-
wardena NK, Pathmeswaran A, et al. (2008) The global
burden of snakebite: A literature analysis and modelling
based on regional estimates of envenoming and deaths.
PLoS Med 5: e218. doi:10.1371/journal.pmed.0050218
2. Warrell DA (1999) WHO Guidelines for the clinical
management of snake bites in the South East Asia
Region. SE Asian J Trop Med Publ Health 30: 1–83.
3. World Health Organization (2007) Rabies and envenom-
ings: A neglected public health issue. Geneva: WHO.
Available at http://www.who.int/bloodproducts/animal_
sera/rabies_envenomings/en/index.html
4. Ariaratnam CA, Thuraisingam V, Kularatne SA, Sheriff MH,
Theakston RD, et al. (2008) Frequent and potentially fatal
envenoming by hump-nosed pit vipers (Hypnale hypnale
and H. nepa) in Sri Lanka: Lack of effective antivenom.
Trans R Soc Trop Med Hyg 102: 1120–1126.
5. Gutie ´rrez JM, Theakston RDG, Warrell DA (2006) Con-
fronting the neglected problem of snake bite envenom-
ing: The need for a global partnership. PLoS Med 3: e150.
doi:10.1371/journal.pmed.0030150
Box 3: Main Challenges
(1) Improving access
Access to care is hindered both by the remoteness of
snake bite–prone areas and by the cost of snake bite
management. A community survey in Nepal showed that
snake bite envenoming represents a substantial financial
burden for rural households [13]. Despite the mushroom-
ing of well-equipped private clinics in some rural areas of
India, poor villagers rarely have access to mechanical
ventilation or dialysis.
(2) Improving clinical management
Simple and standardized protocols on snake bite manage-
ment are needed. Despite the publication of regional
guiding principles [61], national protocols are not always
consistent with each other (e.g., low initial dose of
antivenom advised in Nepal versus high initial dose in
India and Bangladesh), are often not available in peripheral
health structures and are poorly explained to end users.
Moreover, manufacturers’ recommendations are often
misleading [107]. In Nepal, the application of different
protocols may play a role in the wide range (3%–58%) of
case-fatality rates reported from various hospitals [12].
(3) Improving diagnostic and treatment tools
The lack of field-applicable diagnostic tools to identify
snake species contributes to poor case definitions [110],
mismanagement of patients, and uncertainties about
snake bite epidemiology. Snake bite victims in South Asia
are still reliant on old generations of antivenoms, and
several venomous species are not covered by existing
products [92]. The pharmacokinetic and pharmacodynamic
properties, efficacy, and safety of most Indian antivenoms
have never been studied or compared. WHO has recently
endorsed the strengthening of antivenom production, and
efforts are being made to help Indian manufacturers to
improve the quality of existing products [108]. However,
the impact of this approach on the cost of antivenom
production needs to be carefully anticipated and closely
monitored [1].
(4) Improving knowledge
Improving the knowledge of both care-givers and rural
communities is crucial. Health workers in rural districts are
usually poorly trained to deal with this complex emergen-
cy. For example, many doctors in India and Pakistan
appear to be unaware of the criteria for antivenom
administration [73]. Education of rural communities on
snake bite, avoidance of useless or dangerous first-aid
measures, and the importance of rapid transport of victims
to treatment centres should be widely implemented [13].
Box 1. Key Learning Points
N South Asia has the highest incidence and mortality rates
of snake bite in the world.
N Bites by venomous snakes in this region can cause local
tissue damage, neuroparalysis, systemic haemorrhages,
generalized myotoxicity, acute renal failure, or complex
combinations of these.
N Recommended first aid measures include reassurance of
the snake bite victim, immobilization of the bitten limb,
and rapid transport to a competent treatment centre.
N Antivenom is the only specific treatment for snake bite
envenoming, but existing products cover only a very
limited number of medically significant species.
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In practice, strategies to control snake populations and to
prevent snake bites are nonexistent in South Asian countries.
Many bites could be avoided by educating the population at risk.
Sleeping on a cot (rather than on the floor) and under bed nets
decreases the risk of nocturnal bites in Nepal [55,102]. Rubbish,
termite mounds, and firewood, which attract snakes, can be
removed from the vicinity of human dwellings. Attempts can be
made to prevent the proliferation of rodents in the domestic and
peridomestic area. Thatched roofs, and mud and straw walls are
favoured hiding places for snakes and should be checked
frequently. Many bites occur when people walking barefoot or
wearing only sandals accidentally step on a snake. Using a torch/
flashlight while walking on footpaths at night, and wearing boots
[103] and long trousers during agricultural activities, could
significantly reduce the incidence of bites.
A complementary strategy is to decrease the risk of dying from
envenoming snake bites. Many areas where snake bite envenom-
ing occurs are relatively inaccessible by road, especially during the
rainy season, and transport to a health centre sometimes takes
more than 24 hours [14,74,104]. In Nepal, a programme for rapid
transport of snake bite victims by motorcycle volunteers to a
specialized treatment centre significantly reduced the risk of fatal
outcome (Sharma et al., manuscript in preparation).
Conclusion
While sub-Saharan Africa faces a dramatic crisis in antivenom
production and supply [105,106], shortage of antivenom is not the
most pressing issue in South Asia. Indeed, it is estimated that India
produces around one million vials of antivenom each year [107].
Despite these large volumes of production, several challenges
persist that prevent appropriate management of snake bite victims
in South Asia. Poor access to often inadequately equipped and
staffed medical centres in rural areas, high cost of treatment, and
inadequate use of antivenoms are major concerns [108,109].
Increased attention and means should be dedicated to snake bite
envenoming by researchers, funding agencies, pharmaceutical
industries, public health authorities, and supranational organisa-
tions, as all have contributed to keeping this important public
health problem a truly neglected disease.
References
1. Simpson ID, Norris RL (2009) The global snakebite crisis–a public health issue
misunderstood, not neglected. Wilderness Environ Med 20: 43–56.
2. Chippaux JP (1998) Snake-bites: appraisal of the global situation. Bull World
Health Organ 76: 515–524.
3. Gutie ´rrez JM, Theakston RD, Warrell DA (2006) Confronting the neglected
problem of snake bite envenoming: the need for a global partnership. PLoS
Med 3: e150.
4. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK,
Pathmeswaran A, et al. (2008) The global burden of snakebite: a literature
analysis and modelling based on regional estimates of envenoming and deaths.
PLoS Med 5: e218.
5. Ali Z (1990) Snake bite: a medical and public health problem in Pakistan. In:
Gopalakrishnakone P, Chou LM, eds. Snakes of medical importance (Asia
Pacific region) Singapore National University Singapore. pp 447–461.
6. WHO (1987) Wkly Epidemiol Rec 42: 319–320.
7. Kularatne SA (2003) Epidemiology and clinical picture of the Russell’s viper
(Daboia russelii russelii) bite in Anuradhapura, Sri Lanka: a prospective study of
336 patients. Southeast Asian J Trop Med Public Health 34: 855–862.
8. Sarker M, Sarker N, Patwary S (1999) Epidemiological survey of snakebite
incidences in Bangladesh. Dhaka University J Biol Sci 8: 53–68.
9. de Silva A (1981) Snake bite in Anuradhapura District. The Snake 13:
117–130.
10. Sawai Y (1984) Study on deaths due to snakebite in Anuradhapura District, Sri
Lanka. The Snake 16: 7–15.
11. Fox S, Rathuwithana AC, Kasturiratne A, Lalloo DG, de Silva HJ (2006)
Underestimation of snakebite mortality by hospital statistics in the Monaragala
District of Sri Lanka. Trans R Soc Trop Med Hyg 100: 693–695.
12. Sharma SK, Khanal B, Pokhrel P, Khan A, Koirala S (2003) Snakebite-
reappraisal of the situation in eastern Nepal. Toxicon 41: 285–289.
13. Sharma SK, Chappuis F, Jha N, Bovier PA, Loutan L, et al. (2004) Impact of
snake bites and determinants of fatal outcomes in southeastern Nepal.
Am J Trop Med Hyg 71: 234–238.
14. Suleman MM, Shahab S, Rab MA (1998) Snake bite in the Thar Desert. J Pak
Med Assoc 48: 306–308.
15. Ariaratnam CA, Sheriff MH, Theakston RD, Warrell DA (2008) Distinctive
epidemiologic and clinical features of common krait (Bungarus caeruleus) bites in
Sri Lanka. Am J Trop Med Hyg 79: 458–462.
16. (2007) Monsoon Flood in Bangladesh 09 October 2007 Site Report. WHO
SEARO Office.
17. Warrell DA (1995) Clinical toxicology of Snake bites in Asia. In: White MA, ed.
Handbook of clinical toxicology of animal venoms and poisons CRC Press. pp
493–588.
18. Whitaker R, Captain A (2004) Snakes of India, the field guide. Chengalpattu,
India: Draco Books. 483 p.
19. DeSilva A (1990) Colour guide to the snakes of Sri Lanka. Portishead, UK: R &
A Publishing Ltd. 130 p.
20. Khan MS (2002) A guide to the snakes of Pakistan. Frankfurt am Main,
Germany: Chimaira. 265 p.
21. Shah KB, Tiwari S (2004) Herpetofauna of Nepal – a conservation companion.
Kathmandu, Nepal: The World Conservation Union. 237 p.
22. Phillips RE, Theakston RD, Warrell DA, Galigedara Y, Abeysekera DT, et al.
(1988) Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell’s
viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine)
antivenom. Q J Med 68: 691–715.
23. Kochar DK, Tanwar PD, Norris RL, Sabir M, Nayak KC, et al. (2007)
Rediscovery of severe saw-scaled viper (Echis sochureki) envenoming in the Thar
desert region of Rajasthan, India. Wilderness Environ Med 18: 75–85.
24. Gnanathasan CA, Rodrigo PC, Peranantharajah S, Coonghe A, Pieris P. A
case series of envenoming by Saw-scaled viper (Echis carinatus) in Sri Lanka;
2008; Melbourne, Australia.
25. den Enden Erwin V, Emmanuel B (2005) Envenoming by the viperid snake
Eristicophis macmahonii. Toxicon 46: 918–920.
26. Sharma LR, Lal V, Simpson ID (2008) Snakes of medical significance in India:
the first reported case of envenoming by the Levantine viper (Macrovipera
lebetina). Wilderness Environ Med 19: 195–198.
27. Gumprecht A, Tillack F, Orlov NL, Captain A, Ryabov S (2004) Asian pit
vipers. Berlin: Geitje Books.
28. Malhotra A, Thorpe RS (2004) A phylogeny of four mitochondrial gene
regions suggests a revised taxonomy for Asian pitvipers (Trimeresurus and
Ovophis). Mol Phylogenet Evol 32: 83–100.
29. Faiz MA, Chowdhury SK, Hussain I (1997) Snake bite in Chittagong and
Cox’s Bazaar- a hospital based study. Bangladesh J Med 8: 52–57.
30. Tillack F, Shah KB, Gumprecht A, Husain A (2003) Anmerkungen zur
Verbreitung, Morphologie, Biologie, Haltung und Nachzucht der Berg-
Grubenotter Ovophis monticola monticola (Gu ¨nther, 1864) (Serpentes: Viperidae:
Crotalinae). Sauria 25: 29.
31. Wall F (1913) The poisonous terrestrial snakes of our British Indian Dominions
(including Ceylon) and how to recognize them. With symptoms of snake
poisoning and treatment. Bombay: Bombay Natural History Society.
32. Bhattarai B, Shrestha BP, Rahman TR, Sharma SK, Tripathi M (2008)
Complex regional pain syndrome (CRPS) type-1 following snake bite: a case
report. Nepal Med Coll J 10: 278–280.
33. Gowda CD, Rajesh R, Nataraju A, Dhananjaya BL, Raghupathi AR, et al.
(2006) Strong myotoxic activity of Trimeresurus malabaricus venom: role of
metalloproteases. Mol Cell Biochem 282: 147–155.
34. Joseph JK, Simpson ID, Menon NC, Jose MP, Kulkarni KJ, et al. (2007) First
authenticated cases of life-threatening envenoming by the hump-nosed pit viper
(Hypnale hypnale) in India. Trans R Soc Trop Med Hyg 101: 85–90.
35. Premawardena AP, Seneviratne SL, Gunatilake SB, de Silva HJ (1998)
Excessive fibrinolysis: the coagulopathy following Merrem’s hump-nosed viper
(Hypnale hypnale) bites. Am J Trop Med Hyg 58: 821–823.
36. Ariaratnam CA, Thuraisingam V, Kularatne SA, Sheriff MH, Theakston RD,
et al. (2008) Frequent and potentially fatal envenoming by hump-nosed pit
vipers (Hypnale hypnale and H. nepa) in Sri Lanka: lack of effective antivenom.
Trans R Soc Trop Med Hyg 102: 1120–1126.
37. Seneviratne SL, Opanayaka CJ, Ratnayake NS, Kumara KE,
Sugathadasa AM, et al. (2000) Use of antivenom serum in snake bite: a
prospective study of hospital practice in the Gampaha district. Ceylon Med J
45: 65–68.
38. Kularatne SA, Budagoda BD, Gawarammana IB, Kularatne WK (2009)
Epidemiology, clinical profile and management issues of cobra (Naja naja) bites
in Sri Lanka: first authenticated case series. Trans R Soc Trop Med Hyg 103:
923–930.
39. Ahuja ML, Singh G (1954) Snake bite in India. Indian J Med Res 42: 661–686.
www.plosntds.org 7 January 2010 | Volume 4 | Issue 1 | e60340. Harris JB, Faiz MA, Rahman MR, Jalil MA, Ahsan MF, et al. (In press) Snake
bite in Chittagong Division, Bangladesh: a study of bitten patients who
developed no signs of systemic envenoming. Trans R Soc Trop Med Hyg.
41. de Silva A, Mendis S, Warrell DA (1993) Neurotoxic envenoming by the Sri
Lankan krait (Bungarus ceylonicus) complicated by traditional treatment and a
reaction to antivenom. Trans R Soc Trop Med Hyg 87: 682–684.
42. Green EE (1908) Note on the death of a cooly from snake-bite. Spolia
Zeylanica 5: 103.
43. Wall F (1910) Notes on snakes collected in upper Assam. Part II. J Bombay Nat
Hist Soc 19: 825.
44. Kramer E (1977) Zur Schlangenfauna Nepals. Rev Suisse Zool 84: 721–761.
45. Reid HA (1975) Epidemiology of sea-snake bites. J Trop Med Hyg 78:
106–113.
46. Amarasekera N, Jayawardena A, Ariyaratnam A, Hewage UC, de Silva A
(1994) Bite of a sea snake (Hydrophis spiralis): a case report from Sri Lanka. J Trop
Med Hyg 97: 195–198.
47. Senanayake MP, Ariaratnam CA, Abeywickrema S, Belligaswatte A (2005)
Two Sri Lankan cases of identified sea snake bites, without envenoming.
Toxicon 45: 861–863.
48. Fernando B (1977) Kraits and wolfsnakes - the karawalas. Loris 14: 157.
49. Suchithra N, Pappachan JM, Sujathan P (2008) Snakebite envenoming in
Kerala, south India: clinical profile and factors involved in adverse outcomes.
Emerg Med J 25: 200–204.
50. Faiz MA, Rahman MR, Hussain A, Yunus EB, Das JC (1995) A hospital based
study of snake bite in Chittagong Medical College. J Bangladesh Coll Phys Surg
13: 3–8.
51. Warrell DA (1989) Snake venoms in science and clinical medicine. 1. Russell’s
viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg 83:
732–740.
52. Jayakumar M, Prabahar MR, Fernando EM, Manorajan R, Venkatraman R,
et al. (2006) Epidemiologic trend changes in acute renal failure–a tertiary
center experience from South India. Ren Fail 28: 405–410.
53. Reid HA (1964) Cobra-Bites. Br Med J 2: 540–545.
54. Meier J, Stocker KF (1995) Biology and distribution of venomous snakes of
medical importance and the composition of snake venom. In: White MA, ed.
Handbook of clinical toxicology of animal venoms and poisons CRC Press.
pp 367–402.
55. Bawaskar HS, Bawaskar PH (2002) Profile of snakebite envenoming in western
Maharashtra, India. Trans R Soc Trop Med Hyg 96: 79–84.
56. Kularatne SA (2002) Common krait (Bungarus caeruleus) bite in Anuradhapura,
Sri Lanka: a prospective clinical study, 1996–98. Postgrad Med J 78: 276–280.
57. Wall F (1921) Ophidia taprobanica or the snakes of Ceylon. In: Cottle HR, ed.
Colombo: Governmental press Ceylon. pp 529–546.
58. Kopstein F (1930) Die Giftschlangen Javas und ihre Bedeutung fu ¨r den
Menschen. Z Morphol O ¨ kol Tiere 19: 339–363.
59. Prasarnpun S, Walsh J, Awad SS, Harris JB (2005) Envenoming bites by kraits:
the biological basis of treatment-resistant neuromuscular paralysis. Brain 128:
2987–2996.
60. White J (1995) Clinical toxicology of snakebite in Australia and New Guinea.
In: White MA, ed. Handbook of clinical toxicology of animal venoms and
poisons CRC press. pp 595–617.
61. Warrell DA (1999) WHO Guidelines for the clinical management of snake bites
in the South East Asia region. SE Asian J Trop Med Publ Hlth 30: 1–83.
62. Pathmeswaran A, Kasturiratne A, Fonseka M, Nandasena S, Lalloo DG, et al.
(2006) Identifying the biting species in snakebite by clinical features: an
epidemiological tool for community surveys. Trans R Soc Trop Med Hyg 100:
874–878.
63. Le VanDong, Selvanayagam ZE, Gopalakrishnakone P, Eng KH (2002) A new
avidin-biotin optical immunoassay for the detection of beta-bungarotoxin and
application in diagnosis of experimental snake envenomation. J Immunol
Methods 260: 125–136.
64. Ho M, Warrell MJ, Warrell DA, Bidwell D, Voller A (1986) A critical
reappraisal of the use of enzyme-linked immunosorbent assays in the study of
snake bite. Toxicon 24: 211–221.
65. Theakston RD, Lloyd-Jones MJ, Reid HA (1977) Micro-ELISA for detecting
and assaying snake venom and venom-antibody. Lancet 2: 639–641.
66. Brunda G, Sashidhar RB (2007) Epidemiological profile of snake-bite cases
from Andhra Pradesh using immunoanalytical approach. Indian J Med Res
125: 661–668.
67. Brunda G, Sashidhar RB, Sarin RK (2006) Use of egg yolk antibody (IgY) as an
immunoanalytical tool in the detection of Indian cobra (Naja naja naja) venom in
biological samples of forensic origin. Toxicon 48: 183–194.
68. Selvanayagam ZE, Gnanavendhan SG, Ganesh KA, Rajagopal D, Rao PV
(1999) ELISA for the detection of venoms from four medically important
snakes of India. Toxicon 37: 757–770.
69. Le VanDong, Quyen le K, Eng KH, Gopalakrishnakone P (2003)
Immunogenicity of venoms from four common snakes in the south of Vietnam
and development of ELISA kit for venom detection. J Immunol Methods 282:
13–31.
70. Heneine LG, Catty D, Theakston RD (1990) Development of a species-specific
ELISA for Brazilian pit-viper venoms. Braz J Med Biol Res 23: 585–588.
71. Sweet D, Lorente JA, Valenzuela A, Lorente M, Villanueva E (1997) PCR-
based DNA typing of saliva stains recovered from human skin. J Forensic Sci
42: 447–451.
72. Suntrarachun S, Pakmanee N, Tirawatnapong T, Chanhome L, Sitprija V
(2001) Development of a polymerase chain reaction to distinguish monocellate
cobra (Naja kaouthia) bites from other common Thai snake species, using both
venom extracts and bite-site swabs. Toxicon 39: 1087–1090.
73. Simpson ID (2008) A study of the current knowledge base in treating snake bite
amongst doctors in the high-risk countries of India and Pakistan: does snake
bite treatment training reflect local requirements? Trans R Soc Trop Med Hyg
102: 1108–1114.
74. Chauhan S (2005) Pre-hospital treatment of snake envenomation in patients
presented at a tertiary care hospital in northwestern India. J Venom Anim
Toxins incl Trop Dis 11: 275–282.
75. Narvencar K (2006) Correlation between timing of ASV administration and
complications in snake bites. J Assoc Physicians India 54: 717–719.
76. Hati AK, Mandal M, De MK, Mukherjee H, Hati RN (1992) Epidemiology of
snake bite in the district of Burdwan, West Bengal. J Indian Med Assoc 90:
145–147.
77. Sharma SK, Koirala S, Dahal G, Sah C (2004) Clinico-epidemiological
features of snakebite: a study from eastern Nepal. Trop Doct 34: 20–22.
78. Amaral CF, Campolina D, Dias MB, Bueno CM, Rezende NA (1998)
Tourniquet ineffectiveness to reduce the severity of envenoming after Crotalus
durissus snake bite in Belo Horizonte, Minas Gerais, Brazil. Toxicon 36:
805–808.
79. Pochanugool C, Wilde H, Bhanganada K, Chanhome L, Cox MJ, et al. (1998)
Venomous snakebite in Thailand. II: Clinical experience. Mil Med 163:
318–323.
80. Sutherland SK, Coulter AR, Harris RD (1979) Rationalisation of first-aid
measures for elapid snakebite. Lancet 1: 183–185.
81. Blaylock RS (1994) Pressure immobilisation for snakebite in southern Africa
remains speculative. S Afr Med J 84: 826–827.
82. Canale E, Isbister GK, Currie BJ (2009) Investigating pressure bandaging for
snakebite in a simulated setting: bandage type, training and the effect of
transport. Emerg Med Australas 21: 184–190.
83. Simpson ID, Tanwar PD, Andrade C, Kochar DK, Norris RL (2008) The
Ebbinghaus retention curve: training does not increase the ability to apply
pressure immobilisation in simulated snake bite–implications for snake bite first
aid in the developing world. Trans R Soc Trop Med Hyg 102: 451–459.
84. Greenland S, Stewart ME, Hoffman JR (1982) Author’s reply. Annals of
Emergency Medicine 11: 228.
85. Gutie ´rrez JM, Lomonte B, Leon G, Rucavado A, Chaves F, et al. (2007)
Trends in snakebite envenomation therapy: scientific, technological and public
health considerations. Curr Pharm Des 13: 2935–2950.
86. Theakston RD, Phillips RE, Warrell DA, Galagedera Y, Abeysekera DT, et al.
(1990) Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan
cobra (Naja naja naja): efficacy and complications of therapy with Haffkine
antivenom. Trans R Soc Trop Med Hyg 84: 301–308.
87. Fernando P, Dias S (1982) Indian krait bite poisoning. Ceylon Med J 27:
39–41.
88. Sharma N, Chauhan S, Faruqi S, Bhat P, Varma S (2005) Snake envenomation
in a north Indian hospital. Emerg Med J 22: 118–120.
89. Sharma SK, Koirala S, Dahal G (2002) Krait bite requiring high dose
antivenom: a case report. Southeast Asian J Trop Med Public Health 33:
170–171.
90. Shashidharamurthy R, Kemparaju K (2007) Region-specific neutralization of
Indian cobra (Naja naja) venom by polyclonal antibody raised against the
eastern regional venom: A comparative study of the venoms from three
different geographical distributions. Int Immunopharmacol 7: 61–69.
9 1 .T s a iI H ,T s a iH Y ,W a n gY M ,T u nP ,W a r r e l lD A( 2 0 0 7 )V e n o m
phospholipases of Russell’s vipers from Myanmar and eastern India–cloning,
characterization and phylogeographic analysis. Biochim Biophys Acta 1774:
1020–1028.
92. Simpson ID, Norris RL (2007) Snakes of medical importance in India: is the
concept of the ‘‘Big 4’’ still relevant and useful? Wilderness Environ Med 18:
2–9.
93. Ariaratnam CA, Sjostrom L, Raziek Z, Kularatne SA, Arachchi RW, et al.
(2001) An open, randomized comparative trial of two antivenoms for the
treatment of envenoming by Sri Lankan Russell’s viper (Daboia russelii russelii).
Trans R Soc Trop Med Hyg 95: 74–80.
94. Premawardhena AP, de Silva CE, Fonseka MM, Gunatilake SB, de Silva HJ
(1999) Low dose subcutaneous adrenaline to prevent acute adverse reactions to
antivenom serum in people bitten by snakes: randomised, placebo controlled
trial. BMJ 318: 1041–1043.
95. Fan HW, Marcopito LF, Cardoso JL, Franca FO, Malaque CM, et al. (1999)
Sequential randomised and double blind trial of promethazine prophylaxis
against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ
318: 1451–1452.
96. Gawarammana IB, Kularatne SA, Dissanayake WP, Kumarasiri RP,
Senanayake N, et al. (2004) Parallel infusion of hydrocortisone+/2chlorphen-
iramine bolus injection to prevent acute adverse reactions to antivenom for
snakebites. Med J Aust 180: 20–23.
97. Bawaskar HS, Bawaskar PH, Punde DP, Inamdar MK, Dongare RB, et al.
(2008) Profile of snakebite envenoming in rural Maharashtra, India. J Assoc
Physicians India 56: 88–95.
www.plosntds.org 8 January 2010 | Volume 4 | Issue 1 | e60398. Pochanugool C, Limthongkul S, Sitprija V, Benyajati C (1994) Management of
cobra bite by artificial respiration and supportive therapy. J Med Assoc Thai
77: 161–164.
99. Currie B, Fitzmaurice M, Oakley J (1988) Resolution of neurotoxicity with
anticholinesterase therapy in death-adder envenomation. Med J Aust 148:
522–525.
100. Bawaskar HS, Bawaskar PH (2004) Envenoming by the common krait (Bungarus
caeruleus) and Asian cobra (Naja naja): clinical manifestations and their
management in a rural setting. Wilderness Environ Med 15: 257–266.
101. Kularatne SA, Kumarasiri PV, Pushpakumara SK, Dissanayaka WP,
Ariyasena H, et al. (2005) Routine antibiotic therapy in the management of
the local inflammatory swelling in venomous snakebites: results of a placebo-
controlled study. Ceylon Med J 50: 151–155.
102. Chappuis F, Sharma SK, Jha N, Loutan L, Bovier PA (2007) Protection against
snake bites by sleeping under a bed net in southeastern Nepal. Am J Trop Med
Hyg 77: 197–199.
103. Tun-Pe, Aye-Aye-Myint, Khin-Aye-Kyu, Maung-Maung-Toe (2002) Accept-
ability study of protective boots among farmers of Taungdwingyi township.
New Delhi: WHO Regional Office for South-East Asia. pp 7–11.
104. Kulkarni ML, Anees S (1994) Snake venom poisoning: experience with 633
cases. Indian Pediatr 31: 1239–1243.
105. Lalloo DG, Theakston RD, Warrell DA (2002) The African challenge. Lancet
359: 1527.
106. Theakston RD, Warrell DA (2000) Crisis in snake antivenom supply for Africa.
Lancet 356: 2104.
107. Simpson ID, Norris RL (2007) Snake antivenom product guidelines in India:
‘‘the devil is in the details’’. Wilderness Environ Med 18: 163–168.
108. Rabies and Envenomings, A neglected public health issue. Geneva: WHO.
109. Simpson ID (2008) The ‘‘worldwide shortage’’ of antisnake venom: is the only
right answer ‘‘produce more’’ or is it also ‘‘use it smarter?’’. Wilderness Environ
Med 19: 99–107.
110. Isbister GK (2005) Snake antivenom research: the importance of case
definition. Emerg Med J 22: 399–400.
111. Agarwal R, Aggarwal AN, Gupta D, Behera D, Jindal SK (2005) Low dose of
snake antivenom is as effective as high dose in patients with severe neurotoxic
snake envenoming. Emerg Med J 22: 397–399.
112. Agrawal PN, Aggarwal AN, Gupta D, Behera D, Prabhakar S, et al. (2001)
Management of respiratory failure in severe neuroparalytic snake envenom-
ation. Neurol India 49: 25–28.
113. Ariaratnam CA, Meyer WP, Perera G, Eddleston M, Kularatne SA, et al.
(1999) A new monospecific ovine Fab fragment antivenom for treatment of
envenoming by the Sri Lankan Russell’s viper (Daboia russelii russelii): a
preliminary dose-finding and pharmacokinetic study. Am J Trop Med Hyg 61:
259–265.
114. Hansdak SG, Lallar KS, Pokharel P, Shyangwa P, Karki P, et al. (1998) A
clinico-epidemiological study of snake bite in Nepal. Trop Doct 28: 223–226.
115. Hati KA (1988) Clinical features of poisoning by common kraits and treatment
with polyvalent antivenin. The Snake 20: 140–143.
116. Kalantri S, Singh A, Joshi R, Malamba S, Ho C, et al. (2006) Clinical
predictors of in-hospital mortality in patients with snake bite: a retrospective
study from a rural hospital in central India. Trop Med Int Health 11: 22–30.
117. Pandey DP (2007) Epidemiology of snakebites based on field survey in Chitwan
and Nawalparasi districts, Nepal. J Med Toxicol 3: 164–168.
118. Paul V, Pratibha S, Prahlad KA, Earali J, Francis S, et al. (2004) High-dose
anti-snake venom versus low-dose anti-snake venom in the treatment of
poisonous snake bites–a critical study. J Assoc Physicians India 52: 14–17.
119. Tariang DD, Philip PJ, Alexander G, Macaden S, Jeyaseelan L, et al. (1999)
Randomized controlled trial on the effective dose of anti-snake venom in cases
of snake bite with systemic envenomation. J Assoc Physicians India 47:
369–371.
120. Punde DP (2005) Management of snake-bite in rural Maharashtra: a 10-year
experience. Natl Med J India 18: 71–75.
121. Bawaskar HS, Bawaskar PH (1992) Snake bite. Bombay Hospital Journal 34:
190–194.
122. Saini RK, Singh S, Sharma S, Rampal V, Manhas AS, et al. (1986) Snake bite
poisoning presenting as early morning neuroparalytic syndrome in jhuggi
dwellers. J Assoc Physicians India 34: 415–417.
www.plosntds.org 9 January 2010 | Volume 4 | Issue 1 | e603